Ganciclovir prophylaxis after lung and heart-lung transplantation

Transplant International

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Halme, M ^a   Lautenschlager, I ^a   Halme, L ^a   Tukiainen, P ^a   Mattila, S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

CMV infection; Ganciclovir; Lung transplantation; Prophylaxis

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; HEART LUNG TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED; PREMEDICATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEART-LUNG TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREMEDICATION;

EID: 0031609669     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1998.tb01188.x     Document Type: Article

References (12)

1. Bailey TC, Trulock EP, Ettinger NA, Storch GA, Cooper JD, Powderly WG (1992) Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in lung transplant recipients. J Infect Dis 165: 548-552
2. Bando K, Paradis IL, Komatsu K, Konishi H, Matsushima M, Keenan RJ, Hardesty RL, Armitage JM, Griffith BP (1995) Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 109: 49-59
3. Duncan AJ, Dummer JS, Paradis IL, Dauber JH, Yousem SA, Zenati MA, Kormos RL, Griffith BP (1991) Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant 10: 638-646
4. Duncan SR, Paradis IL, Yousem SA, Similo SL, Grgurich WF, Williams PA, Dauber JH, Griffith BP (1992) Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 146: 1419-1425
5. Duncan SR, Grgurich WF, Iacono AT, Burckart GJ, Yousem SA, Paradis IL, Williams PA, Johnson BA, Griffith BP (1994) A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 150: 146-152
6. Ettinger NA, Bailey TC, Trulock EP, Storch GA, Anderson D, Raab S, Spitznagel EL, Dresler C, Cooper JD (1993) Cytomegalovirus infection and pneumonitis. Am Rev Respir Dis 147: 1017-1023
7. Hutter JA, Scott J, Wreghitt T, Higenbottam T, Wallwork J (1989) The importance of cytomegalovirus in heart-lung recipients. Chest 95: 627-631
8. Keenan RJ, Lega ME, Dummer JS, Paradis IL, Dauber JH, Rabinowich H, Yousem SA, Hardesty RL, Griffith BP, Duquesnoy RJ, Zeevi A (1991) Cytomegalovirus serologic status and post-operative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 51: 433-438
9. Lautenschlager I, Suni J, Ahonen J, Grönhagen-Riska C, Ruutu P, Ruutu T, Tukiainen P (1989) Detection of cytomegalovirus (CMV) by early antigen immunofluorescence test and by the conventional tissue culture. Eur J Microbiol Infect Dis 8: 610-613
10. Lautenschlager I, Ahonen J, Eklund B, Höckerstedt K, Isoniemi H, Salmela K, Häyry P (1990) Detection of CMV-specific early antigens from blood leucocytes and bronchoalveolar lavage cells in diagnosis of active CMV infection in transplant patients. Transplant Proc 22: 233
11. Soghikian MV, Valentine VG, Berry GJ, Patel HR, Robbins RC, Theodore J (1996) Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. J Heart Lung Transplant 15: 881-887
12. Trulock EP (1997) Lung transplantation. Am J Respir Crit Care Med 155: 789-818